
|Articles|March 9, 2022
UBC Acquires MarketShare Movers
Acquisition will extend UBC's services to include an affordability solution.
Advertisement
UBC announced that it has acquired MarketShare Movers ("MSM"), a data-driven prescription drug benefit and affordability company. With this acquisition, UBC is extending its services to include an innovative affordability solution to patients and clients.
Read more about the acquistion
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12
2
What is Shadow AI and How is it Impacting Pharma Companies?
3
Agentic AI and the Future of Commercial Excellence in Life Sciences
4
Novo Nordisk Responds to FDA’s Warning Letter Regarding 2025 PADE Inspection
5




